Litcius/Paper detail

Evaluation of SARS-CoV-2 viral RNA in fecal samples

Alvaro Mesoraca, Katia Margiotti, Antonella Viola, Antonella Cima, Davide Sparacino, Claudio Giorlandino

2020Virology Journal51 citationsDOIOpen Access PDF

Abstract

The need for timely establishment of a complete diagnostic protocol of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is demanded worldwide. We selected 15 positive novel coronavirus disease 19 (COVID-19) patients with mild or no symptom. Initially, fecal samples were negative in the 67% (10/15) of the cases, while 33% (5/10) of the cases were positive. After serial virus RNA testing, 73% (11/15) of the cases resulted positive to fecal specimens. In particular, 15 days after the first positive respiratory specimens test, 6 fecal specimens became positive for SARS-CoV-2 RNA, while 13 respiratory test returned negative result. In conclusion, qRT-PCR assays of fecal specimens, is an important step to control infection, suggesting that samples remained positive for SARS-CoV-2 RNA longer time then respiratory tract samples. Our results enhance the recent knowledge on this emerging infectious disease and offer suggestions for a more complete diagnostic strategy.

Topics & Concepts

FecesCoronavirusVirologyBiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Respiratory systemRNACoronaviridaeRespiratory tractVirusDiseaseImmunologyInfectious disease (medical specialty)MedicineInternal medicineMicrobiologyGeneAnatomyBiochemistryCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 Research